Early research (Phase 1)Study completedNCT02570997What this trial is testingAscending Dose Study of CT1812 in Healthy VolunteersWho this might be right forCognitive Impairment Cognition Therapeutics 80
Early research (Phase 1)Study completedNCT00692510What this trial is testingDrug Interaction Study Between AZD3480 and Cytochrome P450Who this might be right forMetabolismAlzheimer's Disease AstraZeneca 18
Testing effectiveness (Phase 2)Study completedNCT03507790What this trial is testingEvaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.Who this might be right forMild to Moderate Alzheimer's Disease Cognition Therapeutics 153
Not applicableWithdrawnNCT04100889What this trial is testingA Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+20 more ProgenaBiome
Testing effectiveness (Phase 2)Ended earlyNCT00895895What this trial is testingStudy Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer DiseaseWho this might be right forAlzheimer Disease Pfizer 526
Testing effectiveness (Phase 2)Study completedNCT00566397What this trial is testingStudy Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 402
Not applicableUnknownNCT04295889What this trial is testingTowards HOMe-based Albuminuria Screening: an Implementation Study Testing Two ApproachesWho this might be right forAlbuminuria University Medical Center Groningen 15,032
Testing effectiveness (Phase 2)UnknownNCT06185543What this trial is testingA Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.Who this might be right forAlzheimer Disease NeuroSense Therapeutics Ltd. 20
Early research (Phase 1)Study completedNCT01548430What this trial is testingA Safety Study of TTP4000 in Subjects With Alzheimer's DiseaseWho this might be right forAlzheimer's Disease vTv Therapeutics 8
Early research (Phase 1)Ended earlyNCT00739037What this trial is testingStudy Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's DiseaseWho this might be right forAlzheimer Disease Wyeth is now a wholly owned subsidiary of Pfizer 10
Large-scale testing (Phase 3)UnknownNCT05811000What this trial is testingClinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's DiseaseWho this might be right forMild Alzheimer Disease Mediforum Ltd., Co. 312
Early research (Phase 1)Study completedNCT03551769What this trial is testingPharmacokinetics of Tricaprilin Including Food Effect on Ketone Body ProductionWho this might be right forAlzheimer Disease Cerecin 20
Not applicableLooking for participantsNCT05010603What this trial is testingLate Onset Alzheimer's DiseaseWho this might be right forAlzheimer Disease Columbia University 10,000
Early research (Phase 1)Study completedNCT00831506What this trial is testingDimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy SubjectsWho this might be right forAlzheimer DiseaseHuntington Disease Pfizer 12
Not applicableStudy completedNCT05350514What this trial is testingPreclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept StudyWho this might be right forDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetes, Youth Onset University of Colorado, Denver 14
Testing effectiveness (Phase 2)Ended earlyNCT02249351What this trial is testingEfficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer TypeWho this might be right forAlzheimer Disease Boehringer Ingelheim 54
Testing effectiveness (Phase 2)Study completedNCT02580305What this trial is testingSUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a StudyWho this might be right forAlzheimer's Disease Suven Life Sciences Limited 564
Post-approval studies (Phase 4)Study completedNCT01921972What this trial is testingThe Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Charite University, Berlin, Germany 232
Testing effectiveness (Phase 2)Study completedNCT02423200What this trial is testingClinical Pharmacology of p38 MAP Kinase Inhibitor, VX-745, in Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild ADWho this might be right forAlzheimer's Disease EIP Pharma Inc 16
Early research (Phase 1)Study completedNCT05408780What this trial is testingA Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy SubjectsWho this might be right forAlzheimer Disease Cerecin 45